1. Home
  2. RGEN vs HCP Comparison

RGEN vs HCP Comparison

Compare RGEN & HCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • HCP
  • Stock Information
  • Founded
  • RGEN 1981
  • HCP 2012
  • Country
  • RGEN United States
  • HCP United States
  • Employees
  • RGEN N/A
  • HCP N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • HCP EDP Services
  • Sector
  • RGEN Health Care
  • HCP Technology
  • Exchange
  • RGEN Nasdaq
  • HCP Nasdaq
  • Market Cap
  • RGEN 7.6B
  • HCP 7.0B
  • IPO Year
  • RGEN N/A
  • HCP 2021
  • Fundamental
  • Price
  • RGEN $160.51
  • HCP $34.33
  • Analyst Decision
  • RGEN Buy
  • HCP Hold
  • Analyst Count
  • RGEN 12
  • HCP 14
  • Target Price
  • RGEN $187.44
  • HCP $32.80
  • AVG Volume (30 Days)
  • RGEN 521.6K
  • HCP 2.5M
  • Earning Date
  • RGEN 02-19-2025
  • HCP 03-04-2025
  • Dividend Yield
  • RGEN N/A
  • HCP N/A
  • EPS Growth
  • RGEN N/A
  • HCP N/A
  • EPS
  • RGEN N/A
  • HCP N/A
  • Revenue
  • RGEN $633,513,000.00
  • HCP $654,890,000.00
  • Revenue This Year
  • RGEN $2.28
  • HCP $17.07
  • Revenue Next Year
  • RGEN $9.88
  • HCP $12.69
  • P/E Ratio
  • RGEN N/A
  • HCP N/A
  • Revenue Growth
  • RGEN N/A
  • HCP 16.29
  • 52 Week Low
  • RGEN $113.50
  • HCP $21.50
  • 52 Week High
  • RGEN $211.13
  • HCP $34.47
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 62.61
  • HCP 61.09
  • Support Level
  • RGEN $150.23
  • HCP $34.15
  • Resistance Level
  • RGEN $160.64
  • HCP $34.47
  • Average True Range (ATR)
  • RGEN 6.76
  • HCP 0.15
  • MACD
  • RGEN 1.14
  • HCP -0.01
  • Stochastic Oscillator
  • RGEN 80.27
  • HCP 66.67

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About HCP HashiCorp Inc.

HashiCorp Inc is engaged in solving the infrastructure challenges of cloud adoption by enabling an operating model that unlocks the full potential of modern public and private clouds. Its cloud operating model provides consistent workflows and a standardized approach to automate the processes involved in delivering applications in the cloud: infrastructure provisioning, security, networking, and application deployment. Its main commercial products are Terraform, Vault, Consul, and Nomad.

Share on Social Networks: